G3 PHARMACEUTICALS

G3 pharmaceuticals Inc. is a development-stage biopharmaceutical company. The company was founded by thought leaders in the field of galectin-3 biology, cardiovascular pharmaceutical development, and carbohydrate drug synthesis and manufacturing. The galectin-3 research by our founders has been cited in the scientific literature over 2,000 times – a testimony to the importance of their studies in understanding the role of galectin-3 and the opportunity for treatment. The team of founders will guide the company in the pursuit of novel pharmaceuticals that inhibit galectin-3 for treatment of serious medical conditions.